Targeting Tumors Without Severe Side Effects Possible Say Sydney Scientists
Nanotechnology is being used by an Australian team to build mini-cells which can specifically attack malignant cancer cells while leaving healthy tissue unaffected.
The new cells are about one-fifth the size of a normal cell and can release drugs directly into cancerous tumors. It is hoped that the new technique could be used to treat cancers in the breast, ovaries, colon and lungs while reducing or eliminating serious side effects such as hair loss, nausea and vomiting.
The research is being conducted by the Sydney-based biotechnology company EnGeneIC and is featured in the journal Cancer Cell.
Source: BBC News
Related Stories: BioSpectrum
Print This
|
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
Browse All Categories: Next article: Prognosis Podcast Provides Important Insights Into Cancer Survival Statistics
Previous article: Dads Without Cancer Can Still Pass On Breast Cancer Genes
